4:01 PM
 | 
May 22, 2019
 |  BC Extra  |  Preclinical News

SR-Tiget-led team boosts ‘don’t eat me’ signals on viral vectors to improve efficacy

Boosting surface levels of a "don't eat me" signal on lentiviral vectors could enable administration of lower gene therapy doses and prevent immune responses by shielding the vectors from phagocytosis.

HIV-derived lentiviral gene therapy vectors integrate into the host genome, offering the possibility of longer-lasting gene expression than adeno-associated viral vectors. But high systemic doses have led to acute...

Read the full 273 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >